Reactive oxygen species (ROS) induced cytokine production and cytotoxicity of PAMAM dendrimers in J774A.1 cells

Toxicology and Applied Pharmacology

Volumn 246, Issue 1-2, 2010, Pages 91-99

  Naha, Pratap C ^a   Davoren, Maria ^a   Lyng, Fiona M ^a   Byrne, Hugh J ^a  

^a DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

Author keywords

Cytokine production; In vitro; Macrophage; Nanotoxicology; PAMAM dendrimers; Reactive oxygen species

Indexed keywords

DENDRIMER; DICHLORODIHYDROFLUORESCEIN; DICHLORODIHYDROFLUORESCEIN DIACETATE; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; POLYAMIDOAMINE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL DEATH; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ANALYSIS; IMMUNOTOXICITY; IN VITRO STUDY; MACROPHAGE; MOUSE; NONHUMAN; OXIDATION; QUANTITATIVE ANALYSIS; TIME;

ANIMALS; CELL LINE, TUMOR; CHEMOKINE CXCL2; CYTOKINES; CYTOTOXICITY TESTS, IMMUNOLOGIC; DENDRIMERS; FEMALE; INTERLEUKIN-6; MACROPHAGES; MICE; MICE, INBRED BALB C; OXAZINES; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA; XANTHENES;

EID: 77953691199     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2010.04.014     Document Type: Article

References (53)

1. Al-Nasiry S., Geusens N., Hanssens M., Luyte C., Pijnenborg R. The use of Alamar blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells. Hum. Prod. 2007, 22:1304-1309.
2. Batista M.L., Santos R.V., Cunha L.M., Mattos K., Oliveira E.M., Seelaender M.C., Costa Rosa L.F. Changes in the pro-inflammatory cytokine production and peritoneal macrophage function in rats with chronic heart failure. Cytokine 2006, 34:284-290.
3. Casey A., Herzog E., Lyng F.M., Byrne H.J., Chambers G., Davoren M. Single walled carbon nanotubes induce indirect cytotoxicity by medium depletion in A549 lung cells. Toxicol. Lett. 2008, 179:78-84.
4. Cheng Y., Xu Z., Ma M., Xu T. Dendrimers as drug carrier: applications in different routes of drug administration. J. Pharm. Sci. 2008, 97:123-143.
5. Chung Y.-J., Yang G.H., Islam Z., Pestka J.J. Up-regulation of macrophage inflammatory protein-2 and complement 3A receptor by the trichothecenes deoxynivalenol and satratoxin G. Toxicology 2003, 186:51-65.
6. Davoren M., Herzog E., Casey A., Cottineau B., Chambers G., Byrne H.J., Lyng F.M. In vitro toxicity evaluation of single walled carbon nanotubes on human A549 lung cells. Toxicol. In Vitro 2007, 21:438-448.
7. Dendritech, Inc. http://www.dendritech.com/pamam.html.
8. De Jong W.H. NanoImpactNet workshop on protocols for assessment of biological hazards of engineered nanoparticles, Lausanne 2009, March.
9. Dobrovolskaia M.A., Aggarwal P., Hall J.B., McNeil S.E. Preclinical study to understand nanoparticle interaction with the immuno system and its potential effects on nanoparticle biodistribution. Mol. Pharm. 2008, 5:487-495.
10. Donaldson K., Tran L., Jimenez L.A., Duffin R., Newby D.E., Mills N., MacNee W., Stone V. Combustion-derived nanoparticles: a review of their toxicology following inhalation exposure. Part Fibre Toxicol. 2005, 2:10.
11. Donaldson K., Aitken R., Tran L., Stone V., Duffin R., Forrest G., Alexaner A. Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and work place safety. Toxicol. Sci. 2006, 92:5-22.
12. Driscoll K.E. TNF-? and MIP-2: role in particle induced inflammation and regulation by oxidative stress. Toxicol. Lett. 2000, 112-113:177-184.
13. Driscoll K.E., Hassenbein D.G., Howard B.W., Isfort R.J., Cody D., Tindal M.H., Carter J.M. Cloning, expression, and functional characterization of rat macrophage inflammatory protein 2: a neutrophil chemoattractant and epithelial cell mitogen. J. Leukoc. Biol. 1995, 58:359-364.
14. Duncan R., Izzo L. Dendrimer biocompatibility and toxicity. Adv. Drug Deliv. Rev. 2005, 57:2215-2237.
15. Emanuele A.D., Attwood D. Dendrimer-drug interactions. Adv. Drug Deliv. Rev. 2005, 57:2147-2162.
16. 6+. Free Radic. Biol. Med. 2005, 39:1499-1511.
17. Gillies E.R., Frechet J.M.J. Dendrimers and dendritic polymers in drug delivery. Drug Discov. Today 2005, 10:35-43.
18. Herzog E., Byrne H.J., Casey A., Davoren M., Lenz A.-G., Maier K.L., Duschl A., Oostingh G.J. SWCNT suppress inflammatory mediator responses in human lung epithelium in vitro. Toxicol. Appl. Pharmacol. 2009, 234:378-390.
19. http://probes.invitrogen.com/media/pis/g002.pdf.
20. Huang R.Q., Qu Y.H., Ke W.L., Zhu J.H., Pei Y.Y., Jiang C. Efficient gene delivery targeted to brain using a transferrin conjugated polyethylene glycol modified polyamidoamine dendrimer. FASEB J. 2007, 21:1117-1125.
21. Hulikova K., Benson V., Svoboda J., Sima P., Fiserova A. N-Acetyl-d-glucosamine-coated polyamidoamine dendrimer modulates antibody formation via natural killer cell activation. Int. Immunopharmacol. 2009, 9:792-799.
22. Kang H., De-Long R., Fisher M.H., Juliano R.L. Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides. Pharm. Res. 2005, 22:2099-2106.
23. Kuo J.H., Jan M.S., Lin Y.L. Interactions between U-937 human macrophages and poly(propyleneimine) dendrimers. J. Control. Release 2007, 120:51-59.
24. Kukowska-Latallo J.F., Candido K.A., Cao Z., Nigavekar S.S., Majoros I.J., Thomas T.P., Balogh L.P., Khan M.K., Baker J.R. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res. 2005, 65:5317-5324.
25. Lanone S., Boczkowski J. Biomedical applications and potential health risks of nanomaterials: molecular mechanisms. Curr. Mol. Med. 2006, 6:651-663.
26. Lee C.C., MacKay J.A., Frechet J.M.J., Szoka F.C. Designing dendrimers for biological applications. Nat. Biotechnol. 2005, 23:1517-1526.
27. Lee J.H., Cha K.E., Kim M.S., Hong H.W., Chung D.J., Ryu G., Myung H. Nanosized polyamidoamine (PAMAM) dendrimer-induced apoptosis mediated by mitochondrial dysfunction. Toxicol. Lett. 2009, 190:202-207.
28. Li N., Sioutas C., Cho A., Schmitz D., Misra C., Sempf J., Wang M., Oberley T., Froines J., Nel A. Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ. Health Perspect. 2003, 111:455-460.
29. Li N., Xia T., Nel A.E. The role of oxidative stress in ambient particulate Matter-induced lung diseases and its implications in the toxicity of engineered nanoparticles. Free Radic. Biol. Med. 2008, 44:1689-1699.
30. Lubos E., Handy D.E., Loscalzo J. Role of oxidative stress and nitric oxide in atherothrombosis. Front. Biosci. 2008, 13:5323-5344.
31. Lynch I., Cedervall T., Lundqvist M., Cabaleiro-Lago C., Linse S., Dawson K. The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Adv. Colloid Interface Sci 2007, 13:4-135.
32. Maeda H., Matsumura Y. A new concept on macromolecular therapeutics in cancer chemotherapy: mechanism of tumouritropic accumulation of proteins and the antitumour agents SMANCS. Cancer Res. 1986, 46:6387-6392.
33. Monteiller C., Tran L., MacNee W., Faux S., Jones A., Miller B., Donaldson K. The proinflammatory effect of low toxicity low solubulity particles, nanoparticles and fine particles on epithelial cell in vitro: the role of surface area. Occup. Environ. Med. 2007, 64:609-615.
34. Mukherjee S.P., Davoren M., Byrne H.J. In vitro mammalian cytotoxicological study of PAMAM dendrimers - towards quantitative structure activity relationships. Toxicol In Vitro 2010, 24:169-177.
35. Naha P.C., Davoren M., Casey A., Byrne H.J. An ecotoxicological study of poly(amidoamine dendrimers-towards quantitative structure activity relationship. Environ. Sci. Technol. 2009, 43:6864-6869.
36. Nel A., Xia T., Madler L., Ning L. Toxic potential of materials at nanolevel. Science 2006, 311:622-627.
37. Oberdörster G., Oberdörster E., Oberdörster A. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 2005, 113:823-839.
38. Organisation for Economic Co-operation and Development Guideline (423) for testing of chemicals: acute oral toxicity-acute toxic class method http://www.oecd.org/dataoecd/17/50/1948370.pdf.
39. Osuchowski M.F., Siddiqui J., Copeland S., Remick D.G. Sequential ELISA to profile multiple cytokines from small volumes. J. Immunol. Methods 2005, 302:172-181.
40. Osuchowski M.F., Welch K., Siddiqui J., Remick D.G. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J. Immunol. 2006, 177:1967-1974.
41. Park E.J., Park K. Oxidative stress and pro-inflammatory response induced by silica nanoparticles in vitro and in vivo. Toxicol. Lett. 2009, 184:18-25.
42. Ragnvaldsson D., Berglind R., Tysklind M., Leffler P. Environmental hazard screening of a metal-polluted site using pressurized liquid extraction and two in vitro bioassays. J. Hum. Environ. 2007, 36:494-501.
43. Rahman I. Regulation of nuclear factor-?B, activator protein-1, and glutathione levels by tumor necrosis factor-? and dexamethasone in alveolar epithelial cells. Biochem. Pharmacol. 2000, 60:1041-1049.
44. Rajananthanan P., Attard G.S., Sheikh N.A., Morrow W.J. Evaluation of novel aggregate structures as adjuvants: composition, toxicity studies and humoral responses. Vaccine 1999, 17:715-730.
45. Sheng K.C., Kalkanidis M., Pouniotis D.S., Esparon S., Tang C.K., Apostolopoulos V., Geoffrey A., Pietersz G.A. Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo. Eur. J. Immunol. 2008, 38:424-436.
46. Stone V., Johnston H., Clift M.J. Air pollution, ultrafine and nanoparticles toxicology: cellular and molecular interactions. IEEE Trans. Nanobioscience 2007, 6:331-340.
47. Svenson S., Tomalia D.A. Dendrimers in biomedical applications - reflections on the field. Adv. Drug Deliv. Rev. 2005, 57:2106-2129.
48. Venuganti V.V.K., Perumal O.P. Effect of poly(amidoamine) (PAMAM) dendrimer on skin permeation of 5-fluorouracil. Int. J. Pharm. 2008, 361:230-238.
49. Walley K.R., Lukacs N.W., Standiford T.J., Strieter R.M., Kunkel S.L. Elevated levels of macrophage inflammatory protein 2 in severe murine peritonitis increase neutrophil recruitment and mortality. Infect. Immun. 1997, 65:3847-3851.
50. Wang W., Xiong W., Wan J., Sun X., Xu H., Yang X. The decrease of PAMAM dendrimer-induced cytotoxicity by PEGylation via attenuation of oxidative stress. Nanotechnology 2009, 11(20(10)):105103.
51. Xia T., Kovochich M., Brant J., Hotze M., Sempf J., Oberley T., Sioutas C., Yeh J.I., Wiesner M.R., Nel A.E. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett. 2006, 6:1794-1807.
52. Xia T., Kovochich M., Liong M., Zink J.I., Nel A.E. Cationic polystyrene nanosphere toxicity depends on cell-specific endocytic and mitochondrial injury pathways. ACS Nano 2008, 2:85-96.
53. Yoo H., Juliano R.L. Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers. Nucleic Acid Res. 2000, 28:4225-4231.